Domalagan, Bb Girl -.

HRN: 22-33-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
AMPICILLIN 500MG (VIAL)
12/18/2022
12/25/2022
IV
135mg
Q12
NB Affected By Maternal UTI
Waiting Final Action 
12/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/18/2022
12/25/2022
IV
41mg
Q24
NB Affected By Maternal UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: